These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35018490)
1. Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors. Engelhardt S; Behling F; Beschorner R; Eckert F; Kohlhof P; Tatagiba M; Tabatabai G; Schuhmann MU; Ebinger M; Schittenhelm J J Cancer Res Clin Oncol; 2022 Apr; 148(4):857-866. PubMed ID: 35018490 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279 [TBL] [Abstract][Full Text] [Related]
3. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients. Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K J Neurosurg; 2021 Mar; 134(3):733-741. PubMed ID: 32059187 [TBL] [Abstract][Full Text] [Related]
9. Genomic Analysis of Dysembryoplastic Neuroepithelial Tumor Spectrum Reveals a Diversity of Molecular Alterations Dysregulating the MAPK and PI3K/mTOR Pathways. Surrey LF; Jain P; Zhang B; Straka J; Zhao X; Harding BN; Resnick AC; Storm PB; Buccoliero AM; Genitori L; Li MM; Waanders AJ; Santi M J Neuropathol Exp Neurol; 2019 Dec; 78(12):1100-1111. PubMed ID: 31617914 [TBL] [Abstract][Full Text] [Related]
10. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1. Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151 [TBL] [Abstract][Full Text] [Related]
11. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle. Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303 [TBL] [Abstract][Full Text] [Related]
12. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas. Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571 [TBL] [Abstract][Full Text] [Related]
13. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas. Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611 [TBL] [Abstract][Full Text] [Related]
14. Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas. Trisolini E; Wardighi DE; Giry M; Bernardi P; Boldorini RL; Mokhtari K; Sanson M J Neurooncol; 2019 Nov; 145(2):241-245. PubMed ID: 31673897 [TBL] [Abstract][Full Text] [Related]
15. Picca A; Berzero G; Bielle F; Touat M; Savatovsky J; Polivka M; Trisolini E; Meunier S; Schmitt Y; Idbaih A; Hoang-Xuan K; Delattre JY; Mokhtari K; Di Stefano AL; Sanson M Neurology; 2018 Jun; 90(23):e2086-e2094. PubMed ID: 29728520 [TBL] [Abstract][Full Text] [Related]
16. Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. Pathak P; Kumar A; Jha P; Purkait S; Faruq M; Suri A; Suri V; Sharma MC; Sarkar C Brain Pathol; 2017 Sep; 27(5):580-589. PubMed ID: 27608415 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847 [TBL] [Abstract][Full Text] [Related]
18. A case of a rosette-forming glioneuronal tumor with clinicopathological features of a dysembryoplastic neuroepithelial tumor and fibroblast growth factor receptor 1 internal tandem duplication. Uchiyama T; Gomi A; Nobusawa S; Fukushima N; Matsubara D; Kawai K Brain Tumor Pathol; 2021 Jul; 38(3):250-256. PubMed ID: 33837479 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection. Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178 [TBL] [Abstract][Full Text] [Related]